PE20141530A1 - Composicion farmaceutica para uso en inflamacion y dolor - Google Patents

Composicion farmaceutica para uso en inflamacion y dolor

Info

Publication number
PE20141530A1
PE20141530A1 PE2013002871A PE2013002871A PE20141530A1 PE 20141530 A1 PE20141530 A1 PE 20141530A1 PE 2013002871 A PE2013002871 A PE 2013002871A PE 2013002871 A PE2013002871 A PE 2013002871A PE 20141530 A1 PE20141530 A1 PE 20141530A1
Authority
PE
Peru
Prior art keywords
pharmaceutical composition
inflammation
pain
composition
ketorolaco
Prior art date
Application number
PE2013002871A
Other languages
English (en)
Spanish (es)
Inventor
Paniagua Maria Angelica Arzola
Salgado Lopez Enrique Raul Garcia
Pelaez Juan Pablo Senosiain
Original Assignee
Senosiain S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senosiain S A De C V Lab filed Critical Senosiain S A De C V Lab
Publication of PE20141530A1 publication Critical patent/PE20141530A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PE2013002871A 2011-06-22 2012-06-21 Composicion farmaceutica para uso en inflamacion y dolor PE20141530A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2011006758A MX357376B (es) 2011-06-22 2011-06-22 Composicion farmaceutica para uso en inflamacion y dolor.

Publications (1)

Publication Number Publication Date
PE20141530A1 true PE20141530A1 (es) 2014-11-12

Family

ID=47422093

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2013002871A PE20141530A1 (es) 2011-06-22 2012-06-21 Composicion farmaceutica para uso en inflamacion y dolor

Country Status (13)

Country Link
AR (1) AR086733A1 (ru)
BR (1) BR112013033007A2 (ru)
CL (1) CL2013003671A1 (ru)
CO (1) CO6831987A2 (ru)
CR (1) CR20130687A (ru)
DO (1) DOP2013000309A (ru)
ES (1) ES2441917B1 (ru)
GT (1) GT201300318A (ru)
MX (1) MX357376B (ru)
NI (1) NI201300142A (ru)
PE (1) PE20141530A1 (ru)
RU (1) RU2604149C2 (ru)
WO (1) WO2012176155A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2586607B1 (es) * 2013-05-27 2017-07-20 Farmacéuticos Rayere, S.A. Composición farmacéutica sinergística de dos analgésicos con distinto perfil farmacocinético

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US5091182A (en) * 1990-07-23 1992-02-25 Syntex (U.S.A.) Inc. Dispensing units for ketorolac topical gel formlations
US5436241A (en) * 1994-01-14 1995-07-25 Bristol-Myers Squibb Company Topical anti-inflammatory compositions containing piroxicam
MXPA02010828A (es) * 2002-11-04 2004-07-16 Leopoldo Espinosa Abdala Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
RU2237470C1 (ru) * 2003-01-27 2004-10-10 Купсин Евгений Вениаминович Комбинированный препарат для устранения симптомов простудных заболеваний и гриппа (варианты)
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
MXPA04009698A (es) * 2004-10-04 2006-04-05 Maria Elena Garcia Armenta Formulaciones farmaceuticas solidas conteniendo diacereina y meloxicam.
WO2007148950A1 (es) * 2006-06-20 2007-12-27 Farmacéuticos Rayere, S.A. Composición farmacéutica sinergística de ketorolaco y clonixinato de lisina
MX2007003948A (es) * 2007-04-02 2009-02-25 World Trade Imp Export Wtie Ag Composicion farmaceutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
US20080026054A1 (en) * 2007-04-27 2008-01-31 Nectid Inc. Novel anelgesic combination

Also Published As

Publication number Publication date
BR112013033007A2 (pt) 2017-01-31
ES2441917R1 (es) 2014-02-19
ES2441917A2 (es) 2014-02-06
DOP2013000309A (es) 2014-04-15
MX2011006758A (es) 2013-01-10
CO6831987A2 (es) 2014-01-10
NI201300142A (es) 2015-02-25
MX357376B (es) 2018-07-06
WO2012176155A1 (es) 2012-12-27
CL2013003671A1 (es) 2014-07-11
AR086733A1 (es) 2014-01-15
RU2013157013A (ru) 2015-07-27
ES2441917B1 (es) 2014-11-25
RU2604149C2 (ru) 2016-12-10
GT201300318A (es) 2015-05-21
CR20130687A (es) 2014-02-21

Similar Documents

Publication Publication Date Title
MX2021004546A (es) Composiciones de suministro de farmaco implantables y metodos de uso de las mismas.
MX361858B (es) Formulación oftálmica de lípido polioxilo o de ácido graso polioxilo y tratamiento de padecimientos oculares.
NZ727975A (en) Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
DOP2011000354A (es) Composiciones sublinguales de dexmedetomidina y metodos de uso de ellas
AR068816A1 (es) Composiciones de brimonidina mejorada para el tratamiento del eritema
AR084932A1 (es) Composicion oftalmica que comprende un androgeno y su uso para la fabricacion de un medicamento util para el tratamiento de una enfermedad ocular resultante de una deficiencia androgenica
WO2015085143A3 (en) Therapeutic agents for skin diseases and conditions
CL2016001411A1 (es) Unidad de dosificación farmacéutica solida de desintegración oral que comprende un componente de estetrol; metodo de preparación; uso para la anticoncepción femenina y en terápia de sustitución hormonal femenina.
MX2022008277A (es) Composiciones de gel para administracion transdermica para maximizar las concentraciones de farmaco en el estrato corneo y suero, y metodos de uso de las mismas.
PH12020550032A1 (en) Gel comprising chlorhexidine
AR060019A1 (es) Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo
CL2008002747A1 (es) Compuestos derivados de furo y tienopirimidina; composicion farmaceutica; metodo para modular la actividad del receptor de histamina h4; y uso en el tratamiento de trastornos tales como inflamacion, trastornos alergicos, dermatologicos, entre otros.
CO6660486A2 (es) Composición tópica famacéutica o cosmética útil para el tratamiento de enfermedades o condiciones que cursan con un déficit de la maduración de la envoltura córnea
WO2014164285A3 (en) Use of levocetirizine and montelukast in the treatment of vasculitis
MX2016015211A (es) Formulaciones topicas y usos de las mismas.
MX369742B (es) Formulación de liberación modificada.
WO2015001163A3 (es) Nanopartículas lipídicas para la cicatrización de heridas
SG10201908690WA (en) Novel method of use and compositions
PE20160850A1 (es) Sistema multiparticulado para administrar drogas
AR094224A1 (es) Composicion farmaceutica en forma de una suspension oral
PE20141530A1 (es) Composicion farmaceutica para uso en inflamacion y dolor
MX2020003697A (es) Formulaciones farmaceuticas que comprenden un agonista del receptor opioide como ingredientes activos, metodos de fabricacion y usos terapeuticos de las mismas.
AU2014216273A8 (en) Topical ocular analgesic agents
EP2570131A4 (en) PREPARATION LEISHMANICIDE AND USE THEREOF
EP2082751A3 (en) Topical formulations in the form of aqueous gels fro the treatment of disorders of the skin and mucous membranes or as vehicules for transdermal administration of natural extractive preparations, substances, molecules and drugs

Legal Events

Date Code Title Description
FA Abandonment or withdrawal
AE Restoration of lapsed or forfeited application
FC Refusal